Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
boston blog main
boston top stories
life sciences
3
×
national blog main
investing
national top stories
agios pharmaceuticals
alphabet
boston
broad institute of harvard and mit
brook byers
cancer
cancer drugs
charles chu
clinical trials
crispr
crispr cas14
david e. shaw
deals
decheng capital
diagnostic
drug discovery
enasidenib
event
fda
google
infectious disease
ipo
ivosidenib
kleiner perkins
life science
mammoth biosciences
materials science
mayfield
medical devices
morphic
national
new york
new york blog main
What
today
3
×
accelerating
attend
available
based
big
bio
biopharma's
biopharma’s
biosciences
bird
boston
breakthroughs
cas
cheaper
company’s
course
crispr
develop
development
diagnostics
digital
discover
early
ends
expects
experimental
faster
future
growing
handiwork
health
helped
internal
ipo
landscape
learn
life
mammoth
medical
Language
unset
3
×
Current search:
today
×
photo
×
" life sciences "
×
unset
×
@xconomy.com
4 years ago
Early Bird Sale Ends Today for Xcelerating Life Sciences Boston: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
